Company: CRAC
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001213900-25-049453
Chunk: 179

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-05-30
Form: S-1
Chunk 179
---
 against us or any members of our management team in their capacity as such, and we and the members of our management team have not been subject to any such proceeding in the 12 months preceding the date of this prospectus. 120

MANAGEMENT Directors, Director Nominees, and Officers

| Name                |     | Age |     | Position                          |
| Prashant Patel      |     |  51 |     | Chief Executive Officer, Chairman |
| Eric Sherb          |     |  38 |     | Chief Financial Officer           |
| Michael L. Peterson |     |  63 |     | Director                          |
| Donald G. Fell      |     |  79 |     | Director                          |
| Avinash Wadhwani    |     |  57 |     | Director                          |
| Mayur Doshi         |     |  63 |     | Director                          |

Prashant Patel(age: 51) serves as Chairman and Chief Executive Officer. Mr. Patel currently serves on the board of Eulogistic Health Inc. (NASDAQ:WGRX) and has previously served on the boards of Trxade Health Inc. (NASDAQ:MEDS) and Sceinture Holdings Inc. (NASDAQ:SCNX). Additionally, Mr. Patel has been a board advisor to several special purpose acquisition companies over the years including Oceantech Acquisitions I Corp, (NASDAQ:OTEC), Powerup Acquisitions Corp, (NASDAQ:PWUP), and Aesther Healthcare Acquisitions Corp (NASDAQ:AEHA). Mr. Patel is a seasoned entrepreneur and a registered pharmacist with experience in multiple aspects of the pharmaceutical, biotech and healthcare industries. Mr. Patel previously started several starts -upsincluding Retail/Community Pharmacy before expanding into pharmaceuticals distribution and sales, focusing on pharmaceutical disposal and reverse distribution. Mr. Patel has also been a consultant to several return logistics pharmaceutical companies over the years. Mr. Patel possesses an excellent vision to bring transparency, efficiency and cost benefits to US pharmaceutical channel partners. After graduating with a BPharm from University of Nottingham/UK, Mr. Patel completed MSC in Transport, Trade & Finance from Cass Business School, City University, UK. Eric Sherb(age: 38) serves as the Chief Financial Officer. serves as the Chief Financial Officer. He is a CPA with 16 years of experience in accounting advisory, auditing and mergers and acquisitions. Mr. Sherb began his career at PricewaterhouseCoopers in New